Chester County News and Community Website
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced positive results from a pilot study using a swine model for Probudur, its long-acting pain relief drug. Probudur, a liposomal …
Virpax Pharmaceuticals Reports Promising Results for Pain Relief Drug Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has announced a collaboration with Merck to evaluate a new cancer treatment. The Phase 2 clinical trial will test Prelude’s investigational drug, …
Prelude Therapeutics Joins Forces with Merck for Cancer Treatment Trial Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) recently disclosed the encouraging results of its Phase III clinical trial related to Parkinson’s disease treatment. The experimental drug, buntanetap, has shown …
Annovis Bio’s Breakthrough in Parkinson’s Treatment: New Drug Buntanetap Shows Promise Read More
PLYMOUTH MEETING, PA — Braeburn Inc. has announced the recent tpublication of a post hoc analysis in JAMA Network Open, revealing promising results for its drug BRIXADI in the fight …
Braeburn’s BRIXADI Shows Promise Against Fentanyl in Opioid Use Disorder Study Read More
KING OF PRUSSIA, PA, and CARY, NC — United BioSource LLC (UBC) and Thread® recently announced the expansion of their SitePlus solution. This joint offering, born from a six-year collaboration, …
United BioSource and Thread Expand Research Solution to Boost Clinical Trial Efficiency Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its innovative cancer treatment, CT-0525. This therapy targets …
FDA Grants Fast Track Status to Carisma Therapeutics’ New Cancer Therapy Read More
EDEN PRAIRIE, MN, and REHOVOT, Israel, and EXTON, PA — Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. have announced the enrollment of the first patient in a pioneering clinical …
Groundbreaking Study to Evaluate 3D Printed Models in Orthopedic Oncology Surgery Read More
LANGHORNE, PA — In a significant advancement for patients suffering from autoimmune Pulmonary Alveolar Proteinosis (aPAP), Savara Inc. has revealed promising outcomes from its IMPALA-2 Phase 3 clinical trial. The …
Savara Inc. Announces Breakthrough in aPAP Treatment with IMPALA-2 Trial Success Read More
KING OF PRUSSIA, PA — In a significant leap forward for clinical trial efficiency and financial management, Greenphire has introduced a suite of next-generation capabilities within their renowned Site Payments …
Greenphire Unveils Advanced Site Payments Solution to Streamline Clinical Trials Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) is taking significant steps to ensure that clinical trials better reflect the diversity of the population they aim to serve. …
FDA Unveils Draft Guidance to Boost Diversity in Clinical Trials Read More